S100A6 binds to annexin 2 in pancreatic cancer cells and promotes pancreatic cancer cell motility
Taoufik Nedjadi(National Guard Health Affairs), Eithne Costello(University of Liverpool), Pilar Navarro(Consejo Superior de Investigaciones Científicas), Rosalind E. Jenkins(University of Liverpool), John P. Neoptolemos(University of Liverpool), Alexei V. Tepikin(University of Liverpool), Fiona Campbell(University of Birmingham), B K Park(University of Liverpool), N.R. Kitteringham(University of Liverpool), Felicity Ashcroft(Norwegian University of Science and Technology)
Cited by 98
Related Papers
What is meant by intention to treat analysis? Survey of published randomised controlled trials
|BMJ|1999|2.2k
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
|The Lancet|2017|1.9k
Effectiveness of brief alcohol interventions in primary care populations
|Cochrane Database of Systematic Reviews|2018|1.7k